Paragon 28 Announces Changes to its Board of Directors
Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced two changes to the composition of its Board of Directors.
- Paragon 28, Inc. (NYSE: FNA), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced two changes to the composition of its Board of Directors.
- Quentin Blackford has joined the Companys Board of Directors and will serve the Company as Chairman of its Compensation Committee and as a member of its Audit Committee.
- We are very excited to have Quentin join our Board of Directors, said Albert DaCosta, CEO and Chairman of Paragon 28.
- I am very grateful to Scott for his service to Paragon 28.